Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
25.94
+0.93 (3.72%)
At close: Mar 6, 2026
SHA:688393 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 95.15 | 67.68 | 90.91 | 217.68 |
Trading Asset Securities | - | 55.33 | 52.56 | 175.54 | 419.42 |
Cash & Short-Term Investments | 264.19 | 150.48 | 120.25 | 266.45 | 637.1 |
Cash Growth | 75.56% | 25.14% | -54.87% | -58.18% | -24.67% |
Accounts Receivable | - | 242.84 | 245.25 | 239.03 | 211.94 |
Other Receivables | - | 4.37 | 4.26 | 4.19 | 4.06 |
Receivables | - | 247.21 | 249.51 | 243.22 | 216.01 |
Inventory | - | 84.44 | 74.97 | 63.07 | 40.57 |
Prepaid Expenses | - | 2.54 | 1.93 | 2.12 | 3.99 |
Other Current Assets | - | 207.58 | 120.92 | 20.22 | 11.51 |
Total Current Assets | - | 692.25 | 567.57 | 595.08 | 909.17 |
Property, Plant & Equipment | - | 298.53 | 314.38 | 327.04 | 276.65 |
Long-Term Investments | - | 241.91 | 402.48 | 373.52 | 86.07 |
Goodwill | - | 26.46 | 26.46 | 29.52 | 29.52 |
Other Intangible Assets | - | 5.58 | 6.47 | 5.78 | 5.85 |
Long-Term Deferred Tax Assets | - | 35.63 | 27.61 | 19.04 | 12.69 |
Long-Term Deferred Charges | - | 40.55 | 32.37 | 15.75 | 4.17 |
Other Long-Term Assets | - | 21.81 | 22.59 | 27.06 | 41.56 |
Total Assets | - | 1,363 | 1,400 | 1,393 | 1,366 |
Accounts Payable | - | 32.68 | 37.14 | 32.59 | 49.76 |
Accrued Expenses | - | 29.39 | 30.63 | 34.31 | 28.14 |
Short-Term Debt | - | 7.3 | 21.2 | 14.3 | 7 |
Current Portion of Leases | - | 1.49 | 2 | 3.26 | 2.54 |
Current Income Taxes Payable | - | 0.88 | 3.02 | 2.1 | 2.11 |
Current Unearned Revenue | - | 6.32 | 6.82 | 12.72 | 8.32 |
Other Current Liabilities | - | 6.44 | 9.52 | 14.99 | 8.97 |
Total Current Liabilities | - | 84.51 | 110.33 | 114.26 | 106.84 |
Long-Term Leases | - | 1.65 | 5.18 | 7.24 | 2.85 |
Long-Term Unearned Revenue | - | 27.54 | 28.19 | 28.94 | 29.89 |
Long-Term Deferred Tax Liabilities | - | 13.37 | 14 | 16.08 | 13.34 |
Other Long-Term Liabilities | - | 3.92 | 3.92 | 3.92 | 3.04 |
Total Liabilities | - | 130.99 | 161.63 | 170.45 | 155.96 |
Common Stock | - | 93.57 | 93.57 | 93.34 | 93.34 |
Additional Paid-In Capital | - | 734.14 | 749.14 | 741.35 | 733.87 |
Retained Earnings | - | 428.16 | 420.9 | 394.29 | 376.79 |
Comprehensive Income & Other | - | -0.12 | - | -0.38 | - |
Total Common Equity | 1,226 | 1,256 | 1,264 | 1,229 | 1,204 |
Minority Interest | - | -24 | -25.31 | -6.27 | 5.72 |
Shareholders' Equity | 1,199 | 1,232 | 1,238 | 1,222 | 1,210 |
Total Liabilities & Equity | - | 1,363 | 1,400 | 1,393 | 1,366 |
Total Debt | 14.29 | 10.44 | 28.39 | 24.8 | 12.39 |
Net Cash (Debt) | 249.89 | 140.04 | 91.86 | 241.64 | 624.71 |
Net Cash Growth | 78.44% | 52.45% | -61.99% | -61.32% | -26.13% |
Net Cash Per Share | 2.67 | 1.51 | 0.96 | 2.55 | 6.66 |
Filing Date Shares Outstanding | 105.59 | 93.57 | 93.57 | 93.34 | 93.34 |
Total Common Shares Outstanding | 93.57 | 93.57 | 93.57 | 93.34 | 93.34 |
Working Capital | - | 607.74 | 457.23 | 480.81 | 802.34 |
Book Value Per Share | 13.10 | 13.42 | 13.50 | 13.16 | 12.90 |
Tangible Book Value | 1,189 | 1,224 | 1,231 | 1,193 | 1,169 |
Tangible Book Value Per Share | 12.71 | 13.08 | 13.15 | 12.78 | 12.52 |
Buildings | - | 256.64 | 256.58 | 238.97 | 216.44 |
Machinery | - | 168.4 | 151.86 | 141.86 | 116.01 |
Construction In Progress | - | 0.74 | 0.19 | 10.56 | 10.99 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.